FDA Adverse Event Injury Summary report: N

2939653-2017-00015

MDR report key: 7023506 · Received November 11, 2017

Report

Report Number
2939653-2017-00015
Event Type
Injury
Date Received
November 11, 2017
Date of Event
October 13, 2017
Report Date
March 12, 2018
PMA / PMN Number
K170718
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

SEVERAL POTENTIAL CAUSES OF THE REPORTED EVENTS WERE IDENTIFIED, BUT THE ACTUAL CAUSE IS NOT DEFINITIVE. THE IMMEDIATE AND LONG TERM HEALTH RISK IS DEFINED BY THE SEVERITY OF INJURIES REPORTED BY THE PHYSICIAN AT SLOAN KETTERING. HOWEVER, WHETHER THROUGH USE ERROR, DEVICE DESIGN, ISSUES WITH LABELING AND TRAINING, OR UNIQUE PATIENT ANATOMY, IF THE LIO DEVICE DELIVERS LASER ENERGY TO AN UNINTENDED TARGET, THE RISK SEVERITY (SERIOUSNESS OF HARM) IS "RESULTS IN PERMANENT IMPAIRMENT OF BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE." BECAUSE THE ROOT CAUSE IS UNKNOWN AND THE PROBABILITY OF OCCURRENCE CANNOT BE DETERMINED BUT THE SEVERITY OF HARM RESULTING FROM LASER DELIVERY TO AN UNINTENDED TARGET IS HIGH, IRIDEX HAS MADE A CORPORATE DECISION TO CONDUCT A VOLUNTARY RECALL OF THE TRUFOCUS LIO PREMIERE. RECALL REPORT # 2939653-02/27/2018-001-R.

Description of Event or Problem · 1

PHYSICIAN REPORTED "AIMING/TREATMENT BEAM REFLECTIONS AND BURNS" AFFECTING THREE SEPARATE PATIENTS. THE PHYSICIAN WAS USING AN IRIDEX OCULIGHT SLX LASER CONSOLE DELIVERING 810NM LASER THROUGH A TRUFOCUS LIO PREMIER TO TREAT PEDIATRIC PATIENTS HAVING MELANOMAS (INTRA-OCULAR TUMORS, RETINOBLASTOMA). THE PHYSICIAN STATED THAT THE LASER ENERGY WAS NOT GOING WHERE HE INTENDED TO PUT IT WHICH RESULTED IN PERMANENT, FOCAL CATARACTS AND PERMANENT DAMAGE TO THE IRIS OF EACH PATIENT. THE PHYSICIAN REPORTED SEEING "REFLECTIONS" OR "RED STREAKS" OF THE LIO AIMING BEAM DURING THE PROCEDURES.

Description of Event or Problem · 1

PHYSICIAN REPORTED "AIMING/TREATMENT BEAM REFLECTIONS AND BURNS" AFFECTING THREE SEPARATE PATIENTS. THE PHYSICIAN WAS USING AN IRIDEX OCULIGHT SLX LASER CONSOLE DELIVERING 810NM LASER THROUGH A TRUFOCUS LIO PREMIER TO TREAT PEDIATRIC PATIENTS HAVING MELANOMAS (INTRA-OCULAR TUMORS, RETINOBLASTOMA). THE PHYSICIAN STATED THAT THE LASER ENERGY WAS NOT GOING WHERE HE INTENDED TO PUT IT WHICH RESULTED IN PERMANENT, FOCUSED CATARACTS AND PERMANENT DAMAGE TO THE IRIS OF EACH PATIENT. THE PHYSICIAN REPORTED SEEING "REFLECTIONS" OR "RED STREAKS" OF THE LIO AIMING BEAM DURING THE PROCEDURES.

Patients

Seq Age Sex Outcome Treatment
1 24 MO Disability